RESMED INC — Director's Dealing 2013

Aug 30, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-08-28

Reporting Person: QUINN MICHAEL A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-28	ResMed Common Stock	M	48000	$16.498	Acquired	335000	Direct
2013-08-28	ResMed Common Stock	S	48000	$48.339	Disposed	287000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-28	ResMed Common Stock Options	$16.498	M	48000	Disposed	2015-07-01	ResMed Common Stock (48000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Chess Depositary Instruments	880000	Direct
ResMed Chess Depositary Instruments	306000	Indirect
ResMed Chess Depositary Instruments	90000	Indirect

Footnotes

F1: Represents date options first became exercisable. Options vest 1/3 each year on the anniversary of the grant.

F2: This transaction was executed in multiple trades at prices ranging from $48.25 to $48.48. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the ransacction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: These shares are held as CDIs on the Australian Securities Exchange which represents 31,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.

F4: These shares are held as CDIs on the Australian Securities Exchange which represents 30,600 NYSE shares. 1 NYSE share is equal to 10 CDIs.

F5: These shares are held as CDIs on the Australian Securities Exchange which represents 9,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.